|
[1]
|
Yin P, Wu JY, Wang LJ, Luo CL, Ouyang LH, Tang XT, et al. The burden of COPD in China and its provinces: findings from the global burden of disease study 2019. Front Public Health 2022;10:859499. https://doi.org/10.3389/fpubh.2022.859499CrossRef
|
|
[2]
|
Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: impact, measurement and mechanisms. Respirology 2015;20(8):1160 − 71. https://doi.org/10.1111/resp.12642CrossRef
|
|
[3]
|
Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet 2022;399(10342):2227 − 42. https://doi.org/10.1016/S0140-6736(22)00470-6CrossRef
|
|
[4]
|
WHO. Chronic obstructive pulmonary disease (COPD). 2023. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). [2023-3-16] |
|
[5]
|
WHO. WHO report on the global tobacco epidemic 2021: addressing new and emerging products. Geneva: WHO; 2022. https://iris.who.int/bitstream/handle/10665/343287/9789240032095-eng.pdf?sequence=1. |
|
[6]
|
Han YT, He Y, Lyu J, Yu CQ, Bian MZ, Lee L. Aging in China: perspectives on public health. Global Health J 2020;4(1):11 − 7. https://doi.org/10.1016/j.glohj.2020.01.002CrossRef
|
|
[7]
|
Fang LW, Gao P, Bao HL, Tang X, Wang BH, Feng YJ, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med 2018;6(6):421 − 30. https://doi.org/10.1016/S2213-2600(18)30103-6CrossRef
|
|
[8]
|
WHO. Advancing COPD care in China through a comprehensive approach. Geneva: WHO; 2023. https://www.who.int/news-room/feature-stories/detail/advancing-copd-care-in-china-through-a-comprehensive-approach. |
|
[9]
|
Liu SW, Wu XL, Lopez AD, Wang LJ, Cai Y, Page A, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ 2016;94(1):46 − 57. https://doi.org/10.2471/BLT.15.153148CrossRef
|
|
[10]
|
Guo K, Yin P, Wang LJ, Ji YB, Li QF, Bishai D, et al. Propensity score weighting for addressing under-reporting in mortality surveillance: a proof-of-concept study using the nationally representative mortality data in China. Popul Health Metr 2015;13:16. https://doi.org/10.1186/s12963-015-0051-3CrossRef
|
|
[11]
|
Vanfleteren LEGW, Spruit MA, Groenen M, Gaffron S, van Empel VPM, Bruijnzeel PLB, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(7):728 − 35. https://doi.org/10.1164/rccm.201209-1665OCCrossRef
|
|
[12]
|
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of copd: 2024 report. 2024. Available: https://goldcopd.org/2024-gold-report/.[2023-12-4]. |
|
[13]
|
Wang ZH, Sun YC. Unraveling the causality between chronic obstructive pulmonary disease and its common comorbidities using bidirectional Mendelian randomization. Eur J Med Res 2024;29(1):143. https://doi.org/10.1186/s40001-024-01686-xCrossRef
|
|
[14]
|
Duvall K, Frank GW. Identifying chronic obstructive pulmonary disease in primary care of urban underserved patients: tools, applications, and challenges. J Natl Med Assoc 2010;102(7):570 − 8. https://doi.org/10.1016/S0027-9684(15)30623-4CrossRef
|
|
[15]
|
Zhou YM, Wang C, Yao WZ, Chen P, Kang J, Huang SG, et al. Current status of prevention and management of chronic obstructive pulmonary disease in rural area in China. Chin J Intern Med 2009;48(5):358 − 61. https://doi.org/10.3760/cma.j.issn.0578-1426.2009.05.003CrossRef
|